Avatar
The New York Times News source @nytimes.com New York City 馃嚭馃嚫 1h

#Ozempic #WeightLoss #HealthCare

Link Preview
www.nytimes.com
Game-Changing Drugs
Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use.
Avatar
Yahoo News source @yahoo.com Sunnyvale, California 馃嚭馃嚫 10h

#Diabetes #WeightLoss #MedicalResearch

Link Preview
www.yahoo.com
Researchers discover new benefit of once-a-day weight loss pill
Add Yahoo as a preferred source to see more of our stories on Google. Researchers have hailed the results of a new study on a once-a-day weight loss pill as an "important advancement" in type 2 diabetes care.
Avatar
Business Insider News source @businessinsider.com New York City 馃嚭馃嚫 11h

#GLP1 #WeightLoss #DiabetesManagement

Link Preview
www.businessinsider.com
Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.
The pill, which analysts say might cost $300 a month, could be available as soon as mid-2026. Better injections and better pills.
Avatar
New York Post News source @nypost.com New York City 馃嚭馃嚫 11h

#GLP1 #WeightLoss #SexualHealth

Link Preview
nypost.com
Exclusive | We lost weight on GLP-1 drugs -- and then we lost our sex drives
Welcome to The Thin Line, The New York Post's series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks.
Avatar
CNN News source @us.cnn.com United States 馃嚭馃嚫 2d

#Pharmaceuticals #WeightLoss #DiabetesMedication

Link Preview
us.cnn.com
Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 | CNN
Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027.
Avatar
Yahoo News source @yahoo.com Sunnyvale, California 馃嚭馃嚫 3d

#ObesityTreatment #WeightLoss #FDAApproval

Link Preview
www.yahoo.com
FDA approves Allurion's PMA application for Gastric Balloon System
Allurion's founder and CEO Dr Shantanu Gaur stated that the Smart Capsule offers a safe and effective alternative to GLP-1s and bariatric surgery, aiming to provide metabolically healthy weight loss and become a standard tool in obesity treatment in the US.
Avatar
New York Post News source @nypost.com New York City 馃嚭馃嚫 1w

#WeightLoss #DiabetesTreatment #GLP1

Link Preview
nypost.com
People dropped out of Eli Lilly's new GLP-1 drug trial because they...
Participants taking the highest dose of Eli Lilly's new GLP-1 drug lost an average of 28. 7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments.
Avatar
Yahoo! News source @ca.style.yahoo.com Sunnyvale, California 馃嚭馃嚫 1w

#Zepbound #Psoriasis #WeightLoss

Link Preview
ca.style.yahoo.com
Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Feb 18 (Reuters) - Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a late-stage study, compared to Taltz alone.
Avatar
Fox News News source @foxnews.com New York City 馃嚭馃嚫 1w

#BodyPositivity #Health #WeightLoss

Link Preview
www.foxnews.com
Former body positivity influencer says movement became 'radical,' admits feeling 'brainwashed'
Dave Danna said the body positivity movement is promoting unhealthy lifestyles after losing nearly 60 pounds over the past six months on his own health journey.
Avatar
Yahoo! Finance News source @ca.finance.yahoo.com United States 馃嚭馃嚫 3w

#WeightLoss #HealthcareAdvertising #SuperBowlAds

Link Preview
ca.finance.yahoo.com
Weight-loss drugs to compete on biggest stage with Super Bowl ads
NEW YORK, Feb 7 (Reuters) - Companies looking to sell weight-loss drugs directly to consumers, including Novo Nordisk's Wegovy, will shell out millions of dollars for celebrity-filled ads during Sunday's Super Bowl with its promise of one of the year's largest global audiences.
Avatar
NBC News News source @nbcnews.com Washington (state) 馃嚭馃嚫 3w

#Wegovy #WeightLoss #HealthCare

Link Preview
www.nbcnews.com
Wegovy pill in high demand in weeks since launch, Novo Nordisk says
Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U. S. in early January.
Avatar
Yahoo News source @yahoo.com Sunnyvale, California 馃嚭馃嚫 4w

#WeightLoss #HealthTrends #GLP1

Link Preview
www.yahoo.com
The disruptive force of weight loss drugs: How GLP-1s do more than shed pounds
Add Yahoo as a preferred source to see more of our stories on Google. There's no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to shed pounds or treat a chronic condition, according to a November survey by health policy organization KFF.
Avatar
NBC News News source @nbcnews.com Washington (state) 馃嚭馃嚫 4w

#WeightLoss #Health #GLP1Medications

Link Preview
www.nbcnews.com
Serena Williams says weight loss drug made her healthier than during her tennis career
Roughly a year after starting a weight loss drug, tennis champion Serena Williams says the medication has made her the healthiest she has ever been.
Avatar
NBC News News source @nbcnews.com Washington (state) 馃嚭馃嚫 4w

#WeightLoss #Health #GLP1Medications

Link Preview
www.nbcnews.com
Serena Williams says weight loss drug made her healthier than during her tennis career
Roughly a year after starting a weight loss drug, tennis champion Serena Williams says the medication has made her the healthiest she has ever been.
Avatar
Yahoo News source @yahoo.com Sunnyvale, California 馃嚭馃嚫 4w

#GLP1 #WeightLossDrugs #HealthRisks

Link Preview
www.yahoo.com
Weight-loss drugs draw thousands of lawsuits alleging serious harm
Add Yahoo as a preferred source to see more of our stories on Google. A Maryland truck driver suffered an "eye stroke" that left him blind, first in one eye and then the other.
W
The Wall Street Journal News source @wsj.com New York City 馃嚭馃嚫 4w

#WeightLoss #ObesityManagement #GLP1Medications

Link Preview
www.wsj.com
Here's What Happens When You Stop Taking Ozempic and Wegovy
Studies show that after stopping the drugs, people typically regain lost weight within about 1. 5 years. Peter Dazeley/Getty Images A recent email ad from a telehealth company selling weight-loss medications features tennis-superstar Serena Williams.
U
USA Today News source @usatoday.com McLean, Virginia 馃嚭馃嚫 4w

#Obesity #WeightLoss #HealthEducation

Link Preview
www.usatoday.com
Wegovy works - at first. That won't end our obesity problem. | Opinion
According to a major UNICEF study, roughly one in 10 children aged between five and 19 years old are believed to be affected by obesity.
Avatar
New York Post News source @nypost.com New York City 馃嚭馃嚫 Jan 22

#WeightLoss #HealthAndWellness #FinancialWellbeing

Link Preview
nypost.com
The average American spends shockingly high amount of money to lose...
For many Americans, the cost of trying to lose weight extends well beyond the scale. A new poll of 2,000 U. S. adults actively trying to lose weight found the average respondent spent $12,308 in 2025 attempting to reach their weight and BMI goals, highlighting what many describe as a quiet but persistent "weight tax.
U
U.S. News & World Report News source @usnews.com Washington (state) 馃嚭馃嚫 Jan 21

#WeightLoss #HealthInnovation #GLP1

Link Preview
www.usnews.com
How GLP-1s Are Reshaping Bodies - and Businesses
Weight-loss drugs like Ozempic and Wegovy are transforming individual Americans - offering easy treatments with quick, noticeable effects.
Avatar
Business Insider News source @businessinsider.com New York City 馃嚭馃嚫 Jan 21

#Obesity #WeightLoss #HealthandWellness

Link Preview
www.businessinsider.com
The eureka moment that drove Oprah to reframe weight loss and banish shame involved a Post-It
A new book, co-written with Dr.